In Vitro Generation of Stem Cell Memory-Like T Cells from Activated T Cells
Adoptive T-cell therapy is an attractive strategy for cancer immunotherapy. The transfer of in vitro expanded tumor-associated antigen (TAA)-specific T cells from patients may effectively fight against the original tumor cells. The chimeric antigen receptor-engineered T (CAR-T) cells are also shown to be a promising therapy for hematologic malignancies. However, one of the limitations of these T-cell-based therapies is a rapid acquisition of tolerant (anergy, deletion, dysfunctional and/or exhausted) phenotypes of T cells during activation in vitro and/or after transfer in vivo. We and others found that stem cell memory T (TSCM) cells are strongly resistant against such tolerance, showing strong expansion and persistence in vivo, and provide long-lasting antitumor effects. Here we describe a protocol for the generation of phenotypically TSCM-like cells (iTSCM cells), which can be induced by simple co-culture of activated T cells with OP9 stroma cells expressing a Notch ligand. We also showed the methods of cancer immunotherapy by using NSG mice.
Key wordsAdoptive T-cell therapy Stem cell memory T cells Notch signaling Co-culture with feeder cells EB virus-specific T cells NSG mice
- 21.Hui-Yuen J et al (2011) Establishment of Epstein-Barr virus growth-transformed lymphoblastoid cell lines. J Vis Exp 57:3321Google Scholar
- 22.Chosewood LC et al (2009) Biosafety in microbiological and biomedical laboratories, 5th edn. U.S. Dept. of Health and Human Services, Public Health Service, Centers for Disease Control and Prevention, National Institutes of Health, Washington, D.C., U.S.Google Scholar